Annexon Inc (ANNX)
7.26
+0.17
(+2.40%)
USD |
NASDAQ |
Nov 05, 14:39
Annexon Price to Book Value: 2.124 for Nov. 5, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
November 04, 2024 | 2.075 |
November 01, 2024 | 2.130 |
October 31, 2024 | 2.142 |
October 30, 2024 | 2.206 |
October 29, 2024 | 2.215 |
October 28, 2024 | 2.215 |
October 25, 2024 | 2.165 |
October 24, 2024 | 2.177 |
October 23, 2024 | 2.148 |
October 22, 2024 | 2.215 |
October 21, 2024 | 2.189 |
October 18, 2024 | 2.189 |
October 17, 2024 | 2.233 |
October 16, 2024 | 2.230 |
October 15, 2024 | 2.180 |
October 14, 2024 | 2.168 |
October 11, 2024 | 2.159 |
October 10, 2024 | 2.054 |
October 09, 2024 | 2.034 |
October 08, 2024 | 2.016 |
October 07, 2024 | 1.797 |
October 04, 2024 | 1.840 |
October 03, 2024 | 1.817 |
October 02, 2024 | 1.878 |
October 01, 2024 | 1.788 |
Date | Value |
---|---|
September 30, 2024 | 1.732 |
September 27, 2024 | 1.797 |
September 26, 2024 | 1.791 |
September 25, 2024 | 1.794 |
September 24, 2024 | 1.843 |
September 23, 2024 | 1.946 |
September 20, 2024 | 2.057 |
September 19, 2024 | 2.056 |
September 18, 2024 | 2.028 |
September 17, 2024 | 2.045 |
September 16, 2024 | 2.094 |
September 13, 2024 | 2.107 |
September 12, 2024 | 1.969 |
September 11, 2024 | 1.808 |
September 10, 2024 | 1.829 |
September 09, 2024 | 1.82 |
September 06, 2024 | 1.682 |
September 05, 2024 | 1.703 |
September 04, 2024 | 1.636 |
September 03, 2024 | 1.583 |
August 30, 2024 | 1.668 |
August 29, 2024 | 1.735 |
August 28, 2024 | 1.738 |
August 27, 2024 | 1.770 |
August 26, 2024 | 1.788 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4056
Minimum
Apr 18 2022
3.880
Maximum
Mar 16 2021
1.690
Average
1.592
Median
Aug 11 2022
Price to Book Value Benchmarks
Arbutus Biopharma Corp | 6.043 |
CEL-SCI Corp | 5.811 |
AIM ImmunoTech Inc | 2.567 |
IGC Pharma Inc | 3.647 |
NovaBay Pharmaceuticals Inc | -- |
Price to Book Value Related Metrics
Price | 7.26 |
Earnings Yield | -16.80% |
Market Cap | 767.05M |